
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.840 | 3.840 | 0.000 |
Shares | 95.550 | 95.550 | 0.000 |
Preferred | 0.610 | 0.610 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.929 | 14.929 |
Price to Book | 1.306 | 1.487 |
Price to Sales | 1.688 | 2.042 |
Price to Cash Flow | 6.519 | 6.243 |
Dividend Yield | 5.376 | 3.757 |
5 Years Earnings Growth | 3.408 | 4.984 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 25.790 | 31.787 |
Industrials | 14.410 | 12.209 |
Consumer Defensive | 11.490 | 7.056 |
Utilities | 11.150 | 10.766 |
Real Estate | 9.520 | 5.740 |
Consumer Cyclical | 7.270 | 8.205 |
Communication Services | 5.300 | 10.395 |
Basic Materials | 4.960 | 5.525 |
Healthcare | 3.690 | 4.323 |
Energy | 3.350 | 4.555 |
Technology | 3.080 | 7.742 |
Number of long holdings: 49
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Malayan Banking | MYL1155OO000 | 9.48 | 9.60 | +2.24% | |
Tenaga Nasional | MYL5347OO009 | 7.30 | 13.30 | +2.15% | |
Public Bank | MYL1295OO004 | 5.19 | 4.29 | +1.90% | |
Gamuda | MYL5398OO002 | 4.21 | 5.40 | +4.25% | |
CIMB Group | MYL1023OO000 | 3.61 | 6.79 | +3.66% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Investment Asia Pacific RE | 413.02M | 8.80 | -2.06 | 3.28 | ||
Manulife Investment Progress Fund | 385.57M | -10.40 | 8.19 | 4.25 | ||
Manulife Investment Dividend Fund | 209.56M | -7.29 | 10.49 | 3.50 | ||
Manulife Investment Pacific Fund | 209.36M | 5.21 | 6.13 | 5.56 | ||
Manulife Investment ML Flexi Fund | 88.58M | -9.33 | 8.15 | 4.20 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review